Qube Research & Technologies Ltd - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 791 filers reported holding GLAXOSMITHKLINE PLC in Q2 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q1 2022$16,258,000
+469.9%
373,241
+476.9%
0.14%
+527.3%
Q4 2021$2,853,000
-43.2%
64,698
-50.8%
0.02%
-65.1%
Q3 2021$5,020,000
+46.2%
131,369
+36.5%
0.06%
+16.7%
Q1 2021$3,434,000
+46.5%
96,215
+51.1%
0.05%
+63.6%
Q4 2020$2,344,000
-52.4%
63,691
-51.3%
0.03%
-52.9%
Q3 2020$4,927,000
+51.7%
130,901
+64.4%
0.07%
+45.8%
Q2 2020$3,247,000
+232.0%
79,600
+282.5%
0.05%
+54.8%
Q4 2019$978,000
-7.6%
20,813
-23.2%
0.03%
-92.4%
Q1 2018$1,058,00027,0980.41%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q2 2021
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 100,000$3,680,00012.40%
Black Creek Investment Management Inc. 7,443,061$273,905,0008.54%
KAHN BROTHERS GROUP INC 1,281,924$47,174,803,0008.23%
Camber Capital Management LP 3,500,000$128,800,0004.52%
Eversept Partners, LP 946,581$35,196,5224.13%
EQUITY INVESTMENT CORP 2,321,164$85,419,0003.98%
Galibier Capital Management Ltd. 575,741$21,187,0003.66%
Keystone Financial Planning, Inc. 217,399$8,000,0003.32%
CLIFFORD CAPITAL PARTNERS LLC 217,817$8,016,0003.14%
CLARK ESTATES INC/NY 485,000$17,848,0002.52%
View complete list of GLAXOSMITHKLINE PLC shareholders